Clint Eastwood files third suit against CBD companies, saying they’re falsely claiming endorsement
Clint Eastwood has filed a third lawsuit alleging CBD companies are falsely claiming he’s endorsing their products. The legal action is the second the legendary actor has filed against Los Angeles-based Norok Innovation Inc. and its CEO Eric Popowicz but includes a different set of defendants, according to Law... Read more
Hydrobuilder Holdings Acquires Hydrobuilder.com and GreenCoast Hydroponics to Form a Leading Omni-channel Seller of Specialty Agriculture and Hydroponics Equipment and Supplies Secures over $70 million in financing from broad base of investors PALM BEACH, Fla.-January 15, 2021-(BUSINESS WIRE)–Hydrobuilder Holdings LLC (“Hydrobuilder Holdings”) today announced its formation through the acquisitions... Read more
Subversive Capital Acquisition Corp. Closes The Largest Cannabis SPAC In History And Announces The Launch Of The Parent Company With Shawn “JAY-Z” Carter, Roc Nation, Caliva, And Left Coast Ventures The Parent Company, Formerly Subversive Capital Acquisition Corp., has Completed its Qualifying Transaction and is Now the Largest Vertically... Read more
Cresco Labs Announces Pricing of Offering of Subordinate Voting Shares CHICAGO, January 15, 2021–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the... Read more
Numinus Announces Grant of Stock Options
Ryan Allway January 15th, 2021 Psychedelics Numinus Wellness Inc. (“Numinus“) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, announces that it has granted 1,975,000 incentive stock options (the “Options“) to directors, officers and employees... Read more
EGF Theramed Raises $352,502 in First Tranche of Private Placement
Ryan Allway January 15th, 2021 Psychedelics EGF Theramed Health Corp. (CSE:TMED)(OTCQB:EVAHF) is pleased to announce that it has completed the first tranche of its previously announced (December 10, 2020) offering (the “Offering“), issuing 2,937,516 units (each a “Unit“) by way of non-brokered private placement at a price of $0.12... Read more
Optimi Health Corp. Receives Health Canada Psychedelic Research Exemption and Files Preliminary Prospectus for Initial Public Offering of Units
Ryan Allway January 15th, 2021 Psychedelics Optimi Health Corp. (“Optimi”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that it has filed a preliminary prospectus (the “Preliminary Prospectus”) with the securities regulatory authorities in each of the provinces... Read more
Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder
Ryan Allway January 15th, 2021 Psychedelics Awakn Life Sciences announced today the selection of contract research organization (‘CRO’), PRA Health Sciences (NASDAQ: PRAH), to conduct a Phase IIb trial studying the effectiveness of MDMA-Assisted Psychotherapy as a treatment for patients with Non-Physically Dependent (‘Harmful Use’) Alcohol Use Disorder (“AUD”).... Read more
The U.S. Census Bureau has announced that it plans to begin collecting data on marijuana tax revenue generated by state governments around the country. The federal agency tracks state tax data as part of quarterly reports it issues to provide benchmark financial indicators and inform economic research. Moving forward,... Read more
FDA’s CBD research plan; NY gov pledges legal marijuana in State of the State; KS lawmakers prep medical cannabis push for 2021 Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )